ANXA1 and syringocystadenoma papilliferum: In the present study, SCAP was associated with an elevated serum AnxA1 concentration compared with non-SCAP, especially in nonsurvivors, suggesting that AnxA1 is a useful biomarker for the pathologic status of SCAP.